Conmed (CNMD) Total Liabilities (2010 - 2026)

Conmed's Total Liabilities history runs 17 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• Quarterly Total Liabilities fell 1.73% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (down 1.73% YoY) and the FY2025 annual result came in at $1.3 billion, down 3.79% from the prior year.
• Total Liabilities was $1.3 billion for Q1 2026 at Conmed, roughly flat from $1.3 billion in the prior quarter.
• Across five years, Total Liabilities topped out at $1.6 billion in Q3 2022 and bottomed at $996.2 million in Q1 2022.
• A 5-year average of $1.4 billion and a median of $1.4 billion in 2022 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities jumped 58.28% — and 2024, when it declined 9.59%.
• Conmed's Total Liabilities stood at $1.6 billion in 2022, then retreated by 5.56% to $1.5 billion in 2023, then fell by 8.34% to $1.3 billion in 2024, then slipped by 3.79% to $1.3 billion in 2025, then advanced by 0.36% to $1.3 billion in 2026.
• Business Quant data shows CNMD's Total Liabilities at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.